Stockwinners Market Radar for November 30, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:06 EST Cathie Wood's ARK Investment bought 143K shares of Pure Storage today

18:30 EST Becton Dickinson reports FDA safety communication doesn't impact BD syringes - Becton Dickinson issued a statement regarding the FDA Safety Communication on evaluation of certain plastic syringes. Eric Borin, president of BD Medication Delivery Solutions said, "The FDA safety notice does not apply to any BD syringes. Essentially all plastic syringes BD provides to the U.S. health care system are manufactured in the United States in Nebraska and Connecticut. BD remains committed to supporting the U.S. health care system and is ready to increase production to help supply those providers who currently purchase syringes impacted by the FDA communication..."

18:23 EST Lyft CEO: We have 45% more driver hours now vs. a year ago - In an interview on CNBC's Mad Money, David Risher said customer obsession drives enterprise value. Employee confidence is the highest it has been in four years, he noted. The company's "women + connect" and airport pickup options are resonating with clients, he added.

18:12 EST Home Depot exec Bastek sells 1,612 common shares - In a regulatory filing, Home Depot executive VP of Merchandising William Bastek disclosed the sale of 1,612 common shares of the company on November 28 at a price of $313.90 per share.

17:53 EST Agilysys director sells $8.17M in common stock as part of option expiry - In a regulatory filing, Agilysys disclosed that its director Michael Kaufman sold 95.8K shares of common stock as part of option expiry in a total transaction size of $8.17M.

17:46 EST Agilon Health director buys $250K in common stock - In a regulatory filing, Agilon Health disclosed that its director Jeffrey Schwaneke bought 22.3K shares of common stock on November 29th in a total transaction size of $250.2K.

17:38 EST Symbotic investor David Ladensohn sold $1.17M in common stock - In a regulatory filing, Symbotic disclosed that its 10% holder David Ladensohn sold 20K shares of common stock on November 28th in a total transaction size of $1.17M.

17:33 EST Dell Technologies expects to return to growth in FY25 - "We expect revenue to return to growth next year, above our long-term financial framework."

17:18 EST General Dynamics awarded $654.5M Army contract - General Dynamics were awarded a modification and will compete for each order of the $654.5M fixed-price with economic-price-adjustment contract for M1128 metal parts programs. Work locations and funding will be determined with each order, with an estimated completion date of April 12, 2028. Army Contracting Command is the contracting activity.

17:06 EST PROOF Acquisition to transfer listing to NYSE American - PROOF Acquisition and following its name change to Volato Group announced that, upon completion of the Business Combination, shares of Volato common stock and warrants will be listed on NYSE American LLC . The Company's decision to transfer to the NYSE American was driven by a number of factors, including more favorable listing standards. Trading is expected to begin on NYSE American on or about December 4, 2023, under the new ticker symbols "SOAR" and "SOAR.WS" for Volato common stock and warrants, respectively, following the consummation of the Business Combination, which is currently expected to occur on or about December 1, 2023.

17:00 EST Aptose names Fletcher Payne chief business officer - Aptose Biosciences announced the appointment of Fletcher Payne to Chief Business Officer, in addition to his role as Senior Vice President, Chief Financial Officer. With a healthcare tenure of more than 25 years, Mr. Payne has held several CFO and senior management positions at biotech companies in addition to finance and accounting roles, and has overseen legal, corporate development and licensing functions. During his career, he has executed a wide array of business transactions totaling more than $3.7B, with healthcare focus in clinical testing, oncology, neurological, and orphan diseases indications. "Fletcher's financial and business oversight has proven to be instrumental as we continue to evolve our business and operations strategies," said William G. Rice, Ph.D., Chairman, President and Chief Executive Officer. "He brings the strategic leadership necessary at a time of significant opportunity for Aptose."

16:57 EST Ulta Beauty jumps 10% to $468.72 after Q3 results beat estimates

16:49 EST Raymond James increases common stock repurchase authorization - Raymond James authorized repurchase of the company's shares of common stock in an aggregate amount of up to $1.5B. The $1.5B authorization replaces the previous repurchase authorization of $1.5B announced on December 1, 2022, under which approximately $700M was remaining as of November 30, 2023. The Board's authorization does not have a fixed expiration date.

16:47 EST Vision Sensing Acquisition to extend business combination period to January 3 - Vision Sensing Acquisition, a special purpose acquisition company, "announced that it has notified Continental Stock Transfer & Trust Company that it intends to extend the date by which the Company must consummate its initial business combination from December 3, 2023, to January 3, 2024, and that its sponsor, Vision Sensing, LLC, intends to deposit into the Company's trust account an aggregate of $60,000 by December 4, 2023. In connection with the Extension, the Company intends to issue to its sponsor a non-interest bearing, unsecured promissory note in the principal amount of $60,000 as consideration for the funding. This will be the second of up to six one-month extensions that the Company is authorized to obtain under its amended and restated certificate of incorporation as recently amended on October 25, 2023."

16:45 EST Guidewire COO Hung sells 6,310 common shares - In a regulatory filing, Guidewire president and COO Priscilla Hung disclosed the sale of 6,310 common shares of the company on November 29 at a price of $100 per share.

16:37 EST Weyerhaeuser purchases timberlands in Southern U.S. - Weyerhaeuser has entered into two distinct agreements with Forest Investment Associates to divest approximately 69,600 acres in Upstate South Carolina for $170M, and to purchase approximately 60,700 acres of high-quality timberlands in Coastal North Carolina, South Carolina and Mississippi for $163M. Key attributes of the transaction include: adding quality timberlands with attractive timber attributes, including mature, highly productive acreage that is well-integrated with existing Weyerhaeuser timberlands and mill operations; fee ownership with 80% planted pine acreage and strong site productivity, delivering strong long-term timber returns; well-stocked timber inventory producing attractive sawlog mix and expected average harvest of 6.9 tons per acre annually over the first five years. Expected average Adjusted EBITDA from timber operations is $130 per acre or $7.7M annually over the first five years. The transaction is subject to customary closing conditions and is expected to close in Q4.

16:35 EST Disney shareholder Blackwells Capital calls for Trian to end board campaign - Blackwells Capital, a shareholder of Disney (DIS) since 2018, issued its support for the ongoing restructuring led by the company's CEO Bob Iger, and "stewarded by an enviable Board of Directors recently enhanced" through the appointments of James Gorman and Jeremy Darroch. Blackwells said that displacing these individuals or other members of the board with Peltz and other Trian selected nominees would deprive shareholders of valuable, experienced voices in the boardroom at a critical time in the company's history. The shareholder said, "Blackwells is concerned that Trian's campaign prioritizes Mr. Peltz's ego over what is best for all Disney shareholders, and that its latest effort may cost Disney shareholders upwards of $50 million and serve only as a value destructive fog for Disney's leadership and Board. Moreover, Blackwells does not believe that Trian's efforts at Disney, or indeed at other public companies, have necessarily served the interests of long-term shareholders. Trian and Mr. Peltz's involvement at Wendy's (WEN) serves as a cautionary tale for Disney shareholders. In an act of nepotism, Mr. Peltz installed his son, Matthew H. Peltz, as the non-executive Vice Chairman and packed the board with business partners and friends, while presiding over a period of disappointing results for Wendy's shareholders." Jason Aintabi, chief investment officer of Blackwells, commented, "Disney has one of the most attractive portfolios of beloved brands and businesses. The combined stewardship of the refreshed Board and the leadership of Mr. Iger, offer Disney shareholders the best opportunity to surface value. Mr. Peltz and Trian need to withdraw this costly and disruptive effort to displace experienced voices in the boardroom and substitute them with Mr. Peltz and his nominees." Aintabi continued, "Mindless, drum-beating activism is not the right strategy for shareholders. Disney's Board is acting in the best interests of all shareholders and should be allowed the time to focus on driving value at one of America's most iconic companies without this fatuous sideshow."

16:34 EST Elastic jumps 14% to $91.80 after Q2 earnings beat, guidance raise

16:33 EST Disney gains 1% afterhours at $93.60 after reinstating dividend payout

16:33 EST Markel COO Bob Cox to depart at year end - Markel President and COO, Global Insurance Operations Bob Cox will be leaving his role December 31, after five years leading successful, profitable growth strategies for the company's global insurance operations. Cox joined Markel in 2018 to oversee Markel's global insurance operations-its Markel Specialty and Markel International divisions. Prior to joining Markel, he held executive leadership insurance positions, including extensive experience in all areas of specialty and commercial property and casualty insurance. With Cox's departure, its Markel Specialty and International insurance divisions will report directly to Noble. Simon Wilson, President Markel International, Alex Martin, President, Markel Specialty, and Bryan Sanders, Chairman, Markel Specialty, will report to Noble effective December 31.

16:27 EST Elastic reports Q3 total subscription count at 20.7K vs. 19.7K in Q3 last year - In Q3, total subscription customer count was approximately 20,700 compared to approximately 20,500 in Q1 FY24, and over 19,700 in Q2 FY23. Total customer count with Annual Contract Value (ACV) greater than $100,000 was over 1,220 compared to over 1,190 in Q1 FY24, and over 1,050 in Q2 FY23. Net Expansion Rate was approximately 110%.

16:23 EST M3-Brigade Acquisition II announces redemption of Class A common stock - M3-Brigade Acquisition II has determined to redeem all of its outstanding Class A common stock, par value $0.0001 per share, previously issued to the public, with such redemption anticipated to be effective on or about December 13, 2023, because the company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. The company expects the last day of trading of its Public Shares, units and warrants to be on or about December 8. If the company has not completed an initial business combination by December 8, the company will cease all operations except for the purpose of winding up, as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the issued and outstanding Public Shares , and subject to approval of remaining stockholders and the board of directors, dissolve and liquidate. The per-share redemption price for the Public Shares is expected to be approximately $10.60. The company expects to retain a portion of the interest earned on the funds deposited in the trust account to pay the company's tax obligations and $100K of dissolution expenses.Following the last day of trading of the company's Public Shares, units and warrants, the company expects that the NYSE will delist its securities.

16:18 EST AIG names Rose Marie Glazer as General Counsel - American International Group announced that Rose Marie Glazer, who served as Interim General Counsel since October 1, 2023, has been named General Counsel, with immediate effect, overseeing AIG's legal, compliance, regulatory and government affairs functions. Ms. Glazer remains an Executive Vice President reporting to Peter Zaffino, AIG Chairman & Chief Executive Officer, and member of AIG's Executive Leadership Team. Most recently, Ms. Glazer served as AIG's Chief Human Resources & Diversity Officer since January 1, 2022.

16:16 EST ACRES Commercial Realty Corp. announces additional $10M share repurchase plan - ACRES Commercial Realty Corp. announced that its board of directors authorized and approved the continued use of its existing share repurchase program, to repurchase up to approximately $4.1M of common stock previously approved by the Board, and an additional $10M of the outstanding shares of both its common and preferred stock.

16:13 EST Dell Technologies COO expects revenue growth heading into FY25 - "Technology is everywhere, and we continue to focus on extending our leadership positions and turning new opportunities into incremental growth," said Jeff Clarke, vice chairman and COO. "Our servers and networking business was up 9% sequentially fueled by customer interest in generative AI. And heading into FY25, we expect revenue growth given the tailwinds to our business."

16:10 EST PagerDuty reports Q3 ARR up 13% at $438.9M - In Q3, reports: "Annual recurring revenue grew 13% year over year to $438.9 million. Customers with annual recurring revenue over $100,000 grew 10% to 778 as of October 31, 2023, compared to 710 in the year ago period. Dollar-based net retention rate of 110% as of October 31, 2023, compared to 123% in the year ago period. Total free and paid customers of more than 27,000 as of October 31, 2023 representing approximately 18% growth year over year. Total paid customers of 15,049 as of October 31, 2023, compared to 15,265 in the year ago period."

16:07 EST Dell Technologies reports Q3 cash flow from operations $2.2B - Cash flow from operations for the third quarter was $2.2B, driven by profitability and strong working capital performance. The company has generated $9.9B of cash flow from operations throughout the last 12 months.

16:00 EST Lattice Semiconductor expands stock repurchase program with $250M authorization - Lattice Semiconductor Corporation announced that its Board of Directors authorized the company to repurchase up to an additional $250M of its outstanding common stock through the end of December 2024. During the fourth quarter of 2023, the company repurchased $50M or approximately 900,000 shares. The company has repurchased a total of approximately 4.8M shares since the fourth quarter of 2020 thereby reducing dilution by 3.4%. Sherri Luther, Chief Financial Officer, said, "With our recent share repurchase in the fourth quarter of 2023, we have executed on our thirteenth consecutive quarter of share buybacks. This latest share repurchase program expansion that we are announcing today is an important component of our capital allocation program and reflects the financial strength of our business, confidence in our long-term financial model, and continued commitment to delivering shareholder value."

15:40 EST Soligenix jumps170% after FDA clears IND application for dusquetide in Behcet's - Shares of Soligenix, a rare disease-focused late-stage biopharma firm, are up 150% or 62c per share to $1.05 per share in late-day trading on Thursday after the FDA cleared the IND application for a Phase 2a clinical trial entitled, "Pilot Study of SGX945 in the Treatment of Aphthous Ulcers in Behcet's Disease." The study is designed to evaluate the safety and efficacy of SGX945 or dusquetide, and is expected to begin patient enrollment in the second half of 2024.

14:24 EST Bombardier 'disappointed' Canada awarded aircraft contract without 'competition' - Bombardier released a statement: "Today, Bombardier and GDMS-C employees, as well as Canadians, political and industry leaders, and suppliers, who have very vocally supported Canadian talent, are all equally disappointed that their Canadian government has decided to award a generational contract without an open and fair competition, and without fully evaluating its home-grown industry's multi-mission aircraft capabilities. Despite multiple conversations with the government, where we requested an RFP or a more detailed framework within which to present key facts and capabilities, no such follow-on opportunities were given to Bombardier, or its partners. No aerospace or third-party experts subsequently evaluated our capabilities. Throughout, we remained resolute and came together to passionately advocate for a next-generation capability and an opportunity for our aerospace industry to shine - we are truly thankful for everyone's effort to that end. The solution we were ready to present would have been a game changer for the Canadian economy - not only would it have created and sustained more than 22,000 full-time jobs, but it would have been a model as many countries around the world are looking at our offering as the true future of multi-mission aircraft. Canada is in a unique position of having a manufacturing hub that is the envy of countries around the globe. There is still a bright future for maritime surveillance platforms that Bombardier is ready, willing and able to offer Canada, and the rest of world, which will be less expensive to acquire, less expensive to operate, saving approximately 30% on operating costs, all while decreasing carbon emission by approximately 40% - in 2023 and beyond, we cannot underestimate how important this is as a key differentiator. All in all, we can all be proud of the next-generation solution we were poised to deliver. We are confident that our product offering will be successful in multiple markets, setting a new standard for maritime patrol. Bombardier Defense has built a successful reputation as the most flexible partner for countries around the world and we look forward to sharing more successes on this front."

14:05 EST Braskem SA trading resumes

14:01 EST DatChat CEO sees potentially growing very quickly in upcoming year

14:00 EST Tanger Factory Chairman Steven Tanger sells $1.6M in company shares - The Chairman of Tanger, Steven Tanger, disclosed the sale of 64,212 shares of company stock at $25.50 per share on November 27, for a total transaction amount of $1,637,406.

13:37 EST Boeing confirms Canada selects P-8A Poseidon as its multi-mission aircraft - The Government of Canada has signed a Foreign Military Sales Letter of Offer and Acceptance for up to 16 Boeing P-8A Poseidon aircraft, as part of the Canadian Multi-Mission Aircraft project. "Canada joins eight defense partners, including all of the FIVE EYES allies, the intelligence alliance that also includes the United States, United Kingdom, Australia and New Zealand, and becomes the fifth NATO nation to have selected the P-8 as its multi-mission aircraft. First delivery is expected in 2026," Boeing stated. Reference Link

13:28 EST Braskem SA trading halted, news pending

12:26 EST Brilliant Acquisition Corp trading resumes

12:00 EST GameStop falls -10.8% - GameStop is down -10.8%, or -$1.76 to $14.49.

12:00 EST Precision Auto Care, Inc falls -41.4% - Precision Auto Care, Inc is down -41.4%, or -$13.26 to $18.75.

12:00 EST Victoria's Secret rises 15.1% - Victoria's Secret is up 15.1%, or $3.56 to $27.14.

11:36 EST Soluna Holdings completes registration for Ancillary Services - Soluna Holdings completed its registration for Ancillary Services to diversify its revenue streams.S oluna registered for ERCOT's Demand Response Program establishing the company as a key contributor to intelligent and flexible energy solutions, promoting environmental and economic advantages for Texas. Soluna will be able to make over $10/MWh in additional revenue to Project Dorothy providing this grid resilience support and potentially reduce its power costs below $20/MWh, making it among the lowest cost players in the industry.

11:34 EST Disney responds to Peltz, recommends support for company's board slate - The Walt Disney Company issued the following statement in response to the statement released by Nelson Peltz, founding partner of Trian, relating to Disney and its Board of Directors: "The Walt Disney Company has a proven track record of delivering long-term value to our shareholders and is in the midst of a significant transformation to reinforce our position as the world's preeminent entertainment company. Over the past twelve months, we restructured the company to restore creativity to the center of all our businesses as we significantly reduce costs and drive efficiencies, and we are on track to achieve about $7.5B in cost savings - $2B more than our original target. Disney is moving from a period of fixing to a new era of building, as the entire media sector navigates the crosscurrents of the competitive landscape for streaming. We are executing on four key building opportunities that will be central to our success: achieving significant and sustained profitability in our streaming business; building ESPN into the preeminent digital sports platform; improving the output and economics of our film studios; and turbocharging growth in our Experiences business. Our extraordinary portfolio of businesses, brands and assets-and the key synergies between them-are the foundation to developing the popular franchises that will continue to drive our strategic success. With one of the strongest balance sheets in the media sector, Disney expects free cash flow to approach pre-COVID levels in fiscal 2024, and the Board and management are steadfast in our commitment to ensuring The Walt Disney Company's long-term success for the benefit of all our shareholders. Disney also continues to refresh its Board of Directors, including the appointments of James P. Gorman, Chairman and Chief Executive Officer of Morgan Stanley, and Sir Jeremy Darroch, a veteran media executive and former Group Chief Executive of Sky, as new directors, as the result of a lengthy and comprehensive search that began in April of this year. Their appointments reflect Disney's commitment to a strong board focused on the long-term performance of the company, strategic growth initiatives, the succession planning process, and increasing shareholder value. As also announced yesterday, Disney board member Francis A. deSouza has decided not to stand for reelection at the annual meeting. Mr. Peltz, in partnership with Isaac Perlmutter, a former Disney executive, intends to take its case to shareholders. Mr. Perlmutter owns 78% of the shares that Mr. Peltz claims beneficial ownership of, or more than 25 million of the 33 million shares. This dynamic is relevant to assessing Mr. Peltz and any other nominees he may put forth as directors, as Mr. Perlmutter was terminated from his employment by Disney earlier this year and has voiced his longstanding personal agenda against Disney's CEO, Robert A. Iger, which may be different than that of all other shareholders. The Disney Board will recommend to shareholders its slate of director nominees in the company's proxy statement to be filed with the Securities and Exchange Commission and distributed to all shareholders eligible to vote at the annual meeting."

11:32 EST ZyVersa Therapeutics announces 1-for-35 reverse stock split - yVersa Therapeutics announces that its board of directors has approved a 1-for-35 reverse stock split of the Company's common stock. The board of directors has also approved an increase in the Company's authorized shares of capital stock. The Company's stockholders approved the reverse stock split and the increase in authorized capital stock at the Company's Annual Meeting of Stockholders held on October 31, 2023. The stockholders granted the board of directors the authority to determine the exact split ratio and when to proceed with the reverse stock split. The reverse stock split will become effective on December 4, 2023 at 4:01 pm, Eastern Time and the Company's common stock is expected to begin trading on a reverse stock split-adjusted basis on The Nasdaq Global Market on December 5, 2023 at market open under the existing ticker symbol, "ZVSA." The reverse stock split is intended to increase the price per share of the Company's common stock to allow the Company to demonstrate compliance with the $1.00 minimum bid price requirement for continued listing on Nasdaq, among other benefits. Likewise, effective November 30, 2023, the Company amended its certificate of incorporation to increase the authorized number of shares of the Company's capital stock from 111,000,000 to 251,000,000 and the number of authorized shares of common stock from 110,000,000 to 250,000,000.

11:18 EST Ucommune International Ltd trading resumes

11:07 EST Walgreens launches Rx Savings Finder - Walgreens (WBA) announced the launch of its new Rx Savings Finder, a digital tool designed to help customers save money on prescription medications. Rx Savings Finder finds free, third-party discount cards, providing patients with a quick and easy way to find lower prices on their Walgreens medications. "Inflation not only impacts our pockets but can have serious implications on health," said Rick Gates, chief pharmacy officer, Walgreens. "Over one-third of Americans have avoided a prescription refill to reduce costs and with over 131 million Americans taking at least one prescription medication, this is very concerning. That is why we have launched Walgreens Rx Savings Finder - to empower our customers with transparent prescription costs and help them save money on medications." Other companies in the space include GoodRx (GDRX). Reference Link

10:28 EST Disney's share price underperforming proxy peers, says Trian

10:25 EST Trian says to take case directly to Disney shareholders

10:25 EST Proof Acquisition I Corp trading resumes

10:06 EST Gaucho Group granted 180-day extension by Nasdaq to regain compliance - Gaucho Group Holdings has been granted a 180-day extension by NASDAQ to regain compliance with the exchange's listing requirements. This extension provides Gaucho Holdings with crucial time and flexibility to implement strategic initiatives and take corrective measures aimed at ensuring full compliance with NASDAQ standards.

10:04 EST Sam's Club to open two distribution centers in St. Louis and Minneapolis area - Sam's Club announced plans to open two new distribution centers in early 2024 outside St. Louis and Minneapolis. The new facilities are part of a multi-year growth plan to transform the supply chain at Sam's Club and evolve network and end-to-end capabilities. The first facility will open in the greater St. Louis area, in January 2024. The 370,000 square-foot facility will be located at 5710 Inner Park Dr., and serve as a distribution center and fulfillment center, creating more than 100 jobs across the region. Hourly associate hiring for the center will begin in early December. Walmart Inc. is a top employer in Illinois with more than 57,000 associates. The Shakopee, Minn., facility will be located at 7400 Hentges Way and will serve as a multipurpose distribution center. The 365,000 square-foot facility is scheduled to open in March 2024, and will employ more than 80 associates. Hiring is already underway. Walmart Inc. employs more than 24,000 associates across Minnesota.

10:01 EST Conduit Pharmaceuticals Inc trading resumes

10:00 EST Precision Auto Care, Inc falls -12.5% - Precision Auto Care, Inc is down -12.5%, or -$4.01 to $28.00.

10:00 EST Big Lots rises 14.2% - Big Lots is up 14.2%, or 68c to $5.48.

10:00 EST REX American Resources rises 31.3% - REX American Resources is up 31.3%, or $11.56 to $48.45.

09:56 EST Amkor to invest $2B to build advanced packaging and test facility in Arizona - Amkor Technology (AMKR) announced its plan to build an advanced packaging and test facility in Peoria, Arizona. By the time of full project completion, Amkor projects to invest approximately $2B and employ approximately 2,000 people at the new facility. "Expansion of a US semiconductor supply chain is underway, and as the largest US-headquartered advanced packaging company, we are excited to lead the charge in bolstering America's advanced packaging capabilities," said Giel Rutten, Amkor's president and chief executive officer. "Semiconductor companies, foundries, and other supply chain partners understand the need to strategically broaden their geographic footprint. The announcement of our new advanced packaging and test facility in Arizona is a clear signal of our intent to help our customers ensure resilient supply chains and be a part of a strong American semiconductor ecosystem." Amkor said it worked closely with Apple (AAPL) on the strategic vision and initial manufacturing capability of the Peoria facility, which will package and test chips produced for Apple at the nearby TSMC (TSM) fab. When the new facility opens, Apple will be its first and largest customer.

09:47 EST Daily S&P Biotech Bear 3x Shares falls -9.3% - Daily S&P Biotech Bear 3x Shares is down -9.3%, or -$1.68 to $16.48.

09:47 EST Precision Auto Care, Inc falls -18.4% - Precision Auto Care, Inc is down -18.4%, or -$5.88 to $26.13.

09:47 EST Big Lots rises 17.1% - Big Lots is up 17.1%, or 82c to $5.62.

09:34 EST Humana, CINQCARE partner for in-home care in New York - CINQCARE and Humana are teaming up to serve Medicare Advantage members throughout New York. Together, the two companies, which share a dedication to comprehensive, whole-person health solutions, aim to improve healthcare challenges and close gaps in specific communities in the state. CINQCARE will offer robust care management to qualifying Humana members including around-the-clock telephonic nurse support and remote monitoring, and at-home services including visits from nurses and physicians.

09:31 EST Lionsgate shareholders approve Neuberger Berman proposal - Neuberger Berman announced that shareholders of Lions Gate Entertainment have voted overwhelmingly to approve a proposal submitted by Neuberger Berman calling upon the Board of Lions Gate to eliminate the company's dual-class share structure.

09:27 EST Sanara MedTech announces publication of study on CellerateRX Surgical Powder - Sanara MedTech announced that the Journal of Surgery has published a retrospective study on CellerateRX Surgical Powder titled "Activated Collagen Powder Significantly Reduces Surgical Site Infections in Patients Undergoing Elective Surgery". About the Study and Key Results: Retrospective study of 5,335 patients undergoing elective surgeries over four years. More than a quarter of the patients received CellerateRX in evaluation of clean or clean contaminated cases. Surgical specialties included general, surgical oncology, orthopedic, vascular, neurosurgery, cardiothoracic, plastic and gynecology. The use of activated collagen in patients undergoing elective surgery resulted in a 59% reduction in surgical site infection rates. This reduction was most pronounced in the clean cases with a 69% decrease in surgical site infection rates.

09:18 EST Altisource Portfolio Solutions announces Hubzu expanded collaboration with NCST - Altisource Portfolio Solutions announced that Hubzu, Altisource's industry leading online auction marketplace, has expanded its collaboration with NCST, a national nonprofit housing organization, to bolster the supply of affordable, single-family homes. This strategic collaboration will offer Hubzu homes that are available for sale under the Federal Housing Administration Claims Without Conveyance of Title second chance program to NCST and their dedicated community of buyers, fortifying neighborhood stability, fostering community wealth, and promoting racial equity. For years, Hubzu has worked hand in hand with NCST, offering REO inventory to their community of home buyers. Today's announcement marks an expansion of this relationship to include Hubzu REO inventory under FHA's CWCOT second chance program, demonstrating the parties' unwavering commitment to transforming housing dreams into reality.

09:17 EST Cyclacel Pharmaceuticals regains compliance with Nasdaq listing rule - Cyclacel Pharmaceuticals announced that it received a notice from The Nasdaq Stock Market indicating that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1), by filing its quarterly report on Form 10-Q for the period ended September 30, 2023, on November 29, 2023 with the Securities and Exchange Commission. Nasdaq Listing Qualifications Department staff has determined that the Company complies with the Rule and advised that the matter is now closed.

09:13 EST Acadia Pharmaceuticals initiates COMPASS PWS study - Acadia Pharmaceuticals announced the initiation of the Phase 3 COMPASS PWS study evaluating the efficacy and safety of carbetocin nasal spray for the treatment of hyperphagia in Prader-Willi syndrome, or PWS. PWS is a rare, neurobehavioral genetic disorder that is estimated to affect 8,000 to 10,000 patients in the United States.1-4 The most common symptom is hyperphagia, which is an unrelenting lack of satiety. Other defining features of PWS may include altered metabolism, developmental delays, behavioral challenges and moderate cognitive deficits.

09:10 EST Treasure Global announces launch of ZCITY's Premium Store - Treasure Global announced the launch of ZCITY's Premium Store, responding to evolving consumer needs and aimed at enhancing gross profit and driving revenue for the Company. In addition, TGL is proud to share that ZCITY has received the silver trophy for Best eCommerce Solution at MARKETING-INTERACTIVE Asia eCommerce Awards 2023, demonstrating its commitment to excellence in the dynamic landscape of digital commerce. "Having observed the evolving trends and user behaviors of our 2.66 million users, we strategically developed the ZCITY Premium Store, an enhanced version of Zmembership. We believe the enhancements will not only retain our existing customers but will attract new users, enhancing overall engagement, as well as driving the growth in transactions and increase in gross profit," said Sam Teo, Chief Executive Officer of Treasure Global.

09:09 EST Scilex announces successful FDA audit of enhanced ZTlido manufacturing facility - Scilex announced the successful completion of a Good Manufacturing Practices, GMP, inspection by the U.S. Food and Drug Administration, FDA, of the enhanced manufacturing facility of Oishi Koseido for ZTlido located in Tosu, Saga, Japan. This successful audit allows Scilex to continue commercializing ZTlido product manufactured at 250kg scale at Oishi's facility. This facility is also the manufacturing site for SP-103 that recently completed trials in acute back pain and neck pain. "This successful FDA GMP inspection highlights the GMP and quality assurance of our partner Oishi's manufacturing facility in Japan, which is essential as we scale the commercial production of ZTlido(R)," said Jaisim Shah, Chief Executive Officer and President of Scilex. "The successful FDA inspection for this enhanced manufacturing site marks an important milestone for Scilex that will enable us to increase our capacity to meet the growing demand for ZTlido."

09:08 EST Sprout Social's community for marketers surpasses 10,000 members - Sprout Social announced that The Arboretum has surpassed 10,000 members. The membership milestone comes less than a year after The Arboretum's public launch-quickly becoming a hub for industry connection, community and mentorship for social and marketing professionals. "We are thrilled to see how quickly The Arboretum has grown and how rapidly it's become a go-to space for marketers of all levels to engage with one another on a rich variety of topics, trends and strategies," said Jamie Gilpin, CMO, Sprout Social. "Reaching this membership milestone is both evidence of our teams' incredible efforts to make this community meaningful and engaging and of a thriving social industry that is constantly innovating and making increasing business impact."

09:07 EST Intapp Documents selected by IBB Law LLP - Intapp announced that IBB Law LLP has selected Intapp Documents to transform Microsoft SharePoint into a purpose-built document management system. IBB Law, a leading West London and Thames Valley law firm, will use Intapp Documents to move document management to the cloud and manage matter-related content across all firm data sources. The firm will also gain greater structure and control around collaboration, versioning, enhanced search, and document co-authoring. With Intapp Documents, IBB Law professionals will have a comprehensive, industry-tailored view of client and matter data within the Microsoft apps they use every day. "We are thrilled that IBB Law is adopting Intapp Documents to enhance knowledge management across the firm," said Pat Archbold, General Manager, Collaboration and Content Solutions at Intapp. "Our collaboration solutions and alignment with Microsoft are helping law firms work smarter and manage an ever-increasing amount of matter-specific data."

09:05 EST LPL Financial: Jerry Madden Jr. joins broker-dealer, RIA, custodial platforms - LPL Financial announced that financial advisor Jerry Madden, Jr., CFA, has joined LPL Financial's broker-dealer, RIA and custodial platforms. He reported having served approximately $140 million in advisory, brokerage and retirement plan assets*, and joins LPL from Cetera. Located in Paramus, N.J., Madden has more than two decades of experience in the financial services industry, and has earned a reputation as a financial advisor that builds trust with his clients by providing them with customized, comprehensive plans designed to build wealth - while preserving assets and income and protecting families from unforeseen risks along the way.

09:03 EST TD Synnex: Patrick Zammit named Chief Operating Officer - TD Synnex announced today that Patrick Zammit has been named Chief Operating Officer, reporting to company CEO Rich Hume effective January 1. In this new role, Zammit will coordinate the company's business strategy to drive profitable growth across all technologies, geographies and vendors, and to accelerate the adoption of new, high-growth technologies around the globe. Zammit has served at TD SYNNEX as president, Europe, since 2017, adding executive responsibility for Asia Pacific and Japan in 2021. A new leader for TD SYNNEX's business in Europe will be announced in the coming weeks.

09:02 EST Bon Natural Life announces advancement in sulforaphane - Bon Natural Life announced an achievement in converting glucoraphanin into sulforaphane, an active ingredient in broccoli extract. BON's dedicated R&D team has conducted extensive research, and completed the design of a new compound system, that, when introduced into the human body, integrates enzymes with broccoli extract, efficiently catalyzing glucoraphanin, a precursor, into sulforaphane. This technological advancement not only boosts the transformation rate and bioavailability of broccoli extract, but also reduces costs significantly, allowing for rapid market expansion. Additionally, it extends the shelf life of extract products, providing convenience to customers. Yongwei Hu, CEO & Chairman of BON, stated, "We believe that our new Broclife products will address the challenges related to both effectiveness and costs in broccoli extract products, and play a crucial role in the global health market. With this innovation, BON hopes to unleash substantial growth with the hope to reach a projected of market of tens of millions of dollars over the next three years. This achievement will not only drive the Company's expansion but also deliver exceptional performance and value to our shareholders."

09:02 EST Syra Health awarded contract to provide social services in Kansas - Syra Health announced its recent contract win with Osawatomie State Hospital and Adair Acute Care in Kansas. Under this agreement, Syra Health will deploy licensed professionals including licensed social workers, licensed master social workers, and licensed clinical social workers, to deliver vital social and therapy services at Osawatomie State Hospital, including Adair Acute Care. The services Syra Health will provide focus on discharge planning and therapy. Osawatomie State Hospital is licensed by the state of Kansas to provide care and treatment for adults diagnosed with psychiatric disorders. This contract marks Syra Health's second healthcare workforce contract in the state of Kansas.

08:55 EST ClimateRock announces termination of business combination agreement - ClimateRock notified E.E.W. Eco Energy World that the Company has elected to terminate the Amended and Restated Business Combination Agreement among the Company, E.E.W. and the other parties thereto, dated as of August 3, 2023, effective immediately, pursuant to Section 9.1(b) and 9.2 thereof, since the conditions to the closing of the initial business combination were not satisfied or waived by the outside date of September 30, 2023. As a result, the Business Combination Agreement is of no further force and effect, except for certain specified provisions in the Business Combination Agreement, which shall survive the Termination and remain in full force and effect in accordance with their respective terms. The Company and its sponsor intend to seek alternative ways to consummate an initial business combination.

08:52 EST LQR House announces 'record-breaking' Black Friday/Cyber Monday weekend - LQR House announces "extraordinary success" during the Black Friday Cyber Monday weekend. By November 30, 2023, LQR House's monthly revenue for November was up over 300% year over year. This remarkable performance has propelled LQR House's overall revenue to unprecedented heights. As Black Friday saw Americans shatter online spending records, CWSpirits.com experienced a substantial surge in both traffic and sales. The Company witnessed a historic surge in sales, with its flagship website, CWSpirits.com, contributing significantly to the November revenue, which totaled an impressive $300,000. This amount comprises revenue from both the LQR House Marketing Contracts and sales on CWSpirits.com.

08:46 EST PodcastOne reports 'record' programmatic revenue in Q2 - PodcastOne announced the highest programmatic revenue in company history for the second fiscal quarter of its fiscal year ending March 31, 2024, 121% growth over the same period last year. Q2 Fiscal Year 2024 programmatic revenue also grew compared to the previous quarter, which had ranked as the company's previous highest quarterly benchmark. As touted by MediaRadar, programmatic advertising is an emerging trend in podcast monetization. PodcastOne's growth percentages put the company well in front of this soon-to-be industry-wide revenue trend. Leveraging Adswizz's ad serving technology, the industry wide shift and growth in programmatic advertising and PodcastOne's expansive, premium inventory of highly sought after hosted podcasts, such as The Fighter & The Kid, The Adam Carolla Podcast, Cold Case Files, Coffee Convos and Off The Vine with Kaitlyn Bristowe, PodcastOne was able to deliver over 229 Million programmatic impressions for Q2 Fiscal Year 2024 an increase in impressions of 79% from the same period last year. PodcastOne is also celebrating its highest average programmatic CPM in Q2 Fiscal Year 2024, marking a 24% growth from the same period last year. PodcastOne's fiscal year concludes March 31, 2024.

08:40 EST FSD Pharma, Celly Nu complete plan of arrangement - FSD Pharma and Celly Nutrition announced the closing of the previously announced proposed distribution of a portion of FSD Pharma's holdings of common shares of Celly Nu to certain securityholders of FSD Pharma through a statutory plan of arrangement under section 182 of the Business Corporations Act, pursuant to the arrangement agreement dated October 4, 2023.

08:39 EST Siyata Mobile announces 1-for-7 reverse stock split - Siyata Mobile will effect a 1-for-7 reverse stock split of its common share, no par value per share. The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on Monday, December 4, 2023, and the Company's Common Share will commence trading on the Nasdaq Capital Market on a post-split basis at the opening of the market on December 4, 2023. The Company's Common Share will continue to trade on the Nasdaq Capital Market under the Company's existing trading symbol, "SYTA," and a new CUSIP number 83013Q 707 has been assigned as a result of the Reverse Stock Split. The Reverse Stock Split is primarily intended to bring the Company into compliance with the $1.00 minimum bid price requirement for maintaining its listing on Nasdaq. There is no guarantee the Company will meet the minimum bid price requirement.

08:37 EST OSI Systems receives $18M contract to enhance airport security Iinfrastruce - OSI Systems announced that its Security division was awarded a contract from an international airport for approximately $18M to provide various checkpoint and hold baggage screening solutions. Among the systems to be provided are the RTT 110 or Real Time Tomography, explosive detection system for screening hold baggage, Metor Walk-Through Metal Detector, and Itemiser 5X explosive trace detection system for secondary screening of passengers. As part of this award, the Company is also engaged to provide comprehensive multi-year maintenance, service, and support. OSI Systems' Chairman and CEO, Deepak Chopra, commented, "We are delighted to work with this major airport customer and look forward to providing our inspection system platforms with advanced technologies that are designed to achieve the highest airport security standards, enhancing both the safety and the overall experience of air passengers."

08:36 EST Reborn Coffee converts $1M of outstanding debt into common equity - Reborn Coffee announced the conversion of $1.0 million of outstanding debt held by the Company's Vice Chairman of the Board of Directors, Dennis Egidi, into common equity. On June 26, 2023, the Company secured a $1.0 million credit facility with DRE, owned and controlled by Dennis Egidi, to fund working capital requirements and operating expenses. Per the terms of the exchange agreement, DRE agreed to exchange, in consideration of surrender and termination of the Loan Note, with an outstanding balance of $1,000,000, for 1,666,667 shares of common stock, par value $0.0001 per share, of the Company at a price per share equal to $0.60 per share. Pursuant to the Exchange Agreement, the Company also granted DRE piggyback registration rights with regard to the Exchange Shares.

08:35 EST Ostin announces major product upgrade to Pintura Photo Sharing product - Ostin Technology Group announces new upgrade to its photo sharing product, Pintura. The new upgrades will elevate user experience with improvements to both Pintura's hardware and software system. The Company plans to launch the upgraded Pintura product at the next Consumer Electronics Show in early 2024, which is also expected to be available for purchase through short-video platforms. "We are dedicated to providing our users with the best possible experience, and these hardware and software enhancements reflect our commitment to innovation and convenience," said Mr. Tao Ling, CEO and Chairman of Ostin Technology Group Co. "With Pintura's refined design, we are confident that users will enjoy an unparalleled stylish photo sharing journey. We also value aftersales user experience, which encourages us to continuously invest in product research and development. And we will continue our goal to improve the way people curate and share their precious moments."

08:33 EST General Motors Defense awarded Department of State contract for SUVs - General Motors subsidiary GM Defense has been awarded a 10-year Indefinite Delivery Indefinite Quantity full-rate production contract by the U.S. Department of State to deliver the next generation Heavy-Duty armored Sport Utility Vehicle - HD SUV - in support of the Department's Diplomatic Security Service. GM Defense will deliver Original Equipment Manufacturer integrated HD SUVs under the contract with a ceiling value of $300M. . GM Defense was awarded an initial task order through the IDIQ contract for vehicles, training and engineering services valued at approximately $25M. This contract follows the development and validation contract awarded in 2021 that delivered prototype vehicles for comprehensive testing and evaluation.

08:32 EST Femasys appoints James Liu as Chief Medical Officer - Femasys announced the appointment of James Liu, M.D., as Chief Medical Officer. Dr. Liu joins Femasys as the company accelerates commercialization of its product pipeline, including a new therapeutic for artificial insemination, FemaSeed. Dr. Liu is Professor Emeritus at Case Western Reserve University after serving for over 21 years as the Chairman, Department of Obstetrics and Gynecology, University Hospital Health System and the Chair, Department of Reproductive Biology, Case Western Reserve University. He also served as the Division head, Reproductive Endocrinology and Infertility at the University of Cincinnati.

08:31 EST ePlus achieves the AWS Resilience Competency - ePlus (PLUS) announced that it has achieved the Amazon Web Services (AMZN) Resilience Competency in the Resilience Recovery category. This specialization recognizes ePlus as an AWS Partner using AWS Resilience Services to provide validated solutions to help customers improve their critical systems availability and resilience posture. As each customer and their critical workloads have unique availability requirements, AWS Resilience Competency Partners provide tailored guidance and solutions to achieve the highest system uptime needs.

08:29 EST Smith-Midland begins production of precast utility manholes for Port of Virginia - Smith-Midland has begun production in their Virginia plant for $1.1M of precast concrete Utility Manholes for the North Norfolk International Terminal Optimization Project, in Norfolk, Virginia. The redevelopment project, consisting of over 74 acres of terminal property, will include multiple underground precast concrete utility boxes for electrical and communication uses. The utility manholes will also include cast iron frames and covers, all of which will be delivered to the site. Production and delivery of the boxes is set to last through 2024. Smith-Midland is designing and manufacturing multiple manholes utilizing ten different sizes with around 40 percent of the total order engineered to be rated for heavy-duty loads up to 100,000 lbs.

08:17 EST Bionano Genomics announces study on OGM's role in diagnosing FSHD - Bionano Laboratories announced the publication by scientists at Revvity Omics, Leiden University Medical Centre, Bombay Hospital, and UT Dallas, of the largest peer-reviewed study to date on the use of optical genome mapping, OGM, to diagnose facioscapulohumeral muscular dystrophy, FSHD. Key findings: Compared to Southern blot, the OGM LDT was 100% accurate and precise; The OGM LDT identified 56% of cases positive for FSHD1; 252/547 cases were referred for concurrent testing for FSHD1 and FSHD2; Sequencing identified FSHD2 in 3.6% of cases; The OGM LDT detected mosaic alleles with at least one contracted 4qA allele in 3% of samples positive for FSHD1; The overall diagnostic yield of OGM and NGS combined was 58%. "Bionano Laboratories has developed a powerful menu of OGM-based LDTs, including one LDT for FSHD1 diagnosis. We are pleased to see this prestigious group of researchers' findings from the largest FSHD study to date utilizing OGM. Using the study's algorithm, researchers may be able to diagnose most cases of FSHD, underscoring OGM's potential to contribute to diagnosis of the disorder, which may lead to better disease management and outcomes," commented Justin Leighton, vice president of laboratory business at Bionano Laboratories.

08:15 EST Enphase Energy launches IQ8P microinverters in Mexico - Enphase Energy has started shipping IQ8P Microinverters, with a peak output AC power of 480 W, in Mexico to support newer high-powered solar modules.

08:14 EST TFF Pharmaceuticals appoints Catherine Lee to board of directors - TFF Pharmaceuticals announced that Catherine Lee, J.D. has been appointed to its Board of Directors. Lee currently advises Neogene Therapeutics, Inc., a private cell therapy company that was acquired by AstraZeneca in January 2023, on a variety of legal matters.

08:12 EST Wearable Devices files U.S. patent for touchless pinch-to-zoom in AR - Wearable Devices announced that it has filed a patent application with the U.S. Patent and Trademark Office, USPTO, for continued parameter adjustment using hand and wrist gestures of augmented reality wearables such as AR and virtual reality headsets. Guy Wagner, Chief Scientist Officer and co-founder of Wearable Devices, commented, "We are introducing a significant leap forward for the wearable technology industry with the application for patent covering a gesture control solution that seamlessly integrates with AR and VR wearable devices. The adoption rate of new technologies such as AR and VR headsets is known to be limited by the capabilities of the user interface and experience with these devices. By allowing users to access a familiar and comfortable interaction with new technologies, we believe that we are significantly enhancing the adoptability of these devices."

08:11 EST Cenntro Electric postpones reverse stock split - Cenntro Electric announced that the planned reverse split of its outstanding common stock that was to be effective on December 1 has been postponed. The effective date of the reverse stock split cannot be determined until Depository Trust and Clearing Corporation, or DTCC, eligibility is confirmed. The company expects to receive confirmation of DTCC eligibility in the coming days and will provide an update as to the effective date of the reverse stock split as soon as practicable. The purpose of the previously announced 1-for-10 reverse stock split of its outstanding common stock is to regain compliance with the minimum $1.00 bid price per share requirement of Nasdaq Listing Rule 5550 by December 18 and the company has no reason to believe it will not meet that deadline.

08:10 EST Cibus announces publication of its paper on Industrializing Gene Editing - Cibus announced that its paper on Industrializing Gene Editing in Brassica napus was published in the International Journal of Plant Biology. "The ability to scale breeding in a precise and repeatable process is the central breakthrough of our high-speed breeding process, which we refer to as the Trait Machine System. Our scale breakthroughs in breeding in Brassica napus in our San Diego trait production facility is driving the speed and number of edited seed transfers of our pod shatter reduction trait to our major seed company customers," stated Andrew Walker, Vice President of Trait Production at Cibus. "While we focus on our initial three-crop, five-trait model, our continued breakthroughs developing additional single cell regeneration systems in multiple crops is expanding our ability to bring new scaled breeding processes and new trait opportunities to more crops in the future, especially the major oil and cereal crops."

08:08 EST Roche, Shape expand collaboration with additiona of new target - ShapeTX announced the expansion of its partnership with Roche, with Roche adding a new target to their ongoing collaboration, which was initially established in August 2021. This expansion marks the beginning of a new program where ShapeTX will use its proprietary AI-powered RNA editing platform to develop a potential one-time therapy for patients with high unmet needs for an undisclosed disease affecting millions of people worldwide. During the course of the partnership, ShapeTX will conduct preclinical research to identify and deliver development candidates discovered by its AI-powered RNAfix platform. Roche will be responsible for the final preclinical development as well as clinical development and worldwide commercialization of any potential products resulting from the collaboration. Under the terms of the agreement, ShapeTX will receive a milestone payment and is eligible to receive development, regulatory and sales milestone payments. ShapeTX is also eligible to receive tiered royalties on future sales of products resulting from the collaboration.

08:07 EST United Airlines expands in Houston with $2.6B Terminal project - United announced growth plans in Houston that include a $2.6B renovation and expansion of Terminal B at George Bush Intercontinental Airport, a new United ClubSM location and Early Bag Storage facility as well as a new direct flight to Georgetown, Guyana. Terminal B investments include expansion of 40 gates for larger aircraft, allowing for 40% more people to fly from George Bush Intercontinental Airport. New United Club will be the largest in the nation and Early Bag Storage facility is only one of its kind in North America. Airline expects to create 1,500 United positions in Houston next year and another 4,000 construction-related jobs throughout the project.

08:05 EST Advantage Solutions hires McRoskey as Chief Growth Officer - Advantage Solutions announced the appointment of Brian McRoskey as Chief Growth Officer, effective January 1, 2024. McRoskey will report directly to Dave Peacock, CEO of Advantage Solutions. McRoskey joins Advantage Solutions after spending 17 years at Bain & Company, where he collaborated with senior executives in the consumer packaged goods industry to solve their toughest strategic challenges.

08:05 EST Teledyne's contact image sensors are now in production - Teledyne DALSA announces that its AxCIS family of high-speed and high-resolution fully integrated line scan imaging modules are in production. These easy-to-use Contact Image Sensors, CIS, combine sensors, lenses, and lights all-in-one, offering a lower cost inspection system for many demanding machine vision applications. Powered by Teledyne's multiline CMOS image sensors, AxCIS delivers superior image quality, up to 120 kHz line rates for mono, or 60 kHz x 2 for HDR imaging, at a pixel size of 28 microm or 900 dpi resolution, so that defects can be detected with unprecedented precision.

08:04 EST Kroger reports Q3 gross margin 22% of sales - Gross margin was 22.0% of sales for the third quarter. The FIFO gross margin rate, excluding fuel, increased 3 basis points compared to the same period last year. The increase in the FIFO gross margin rate, excluding fuel, was primarily attributable to Our Brands performance, sourcing benefits and the effect of our terminated agreement with Express Scripts, partially offset by higher shrink and advertising costs, and increased price investments.

08:03 EST Academy Sports board approves $600M share repurchase program - Subsequent to the end of the third quarter, on November 29, 2023, Academy's Board of Directors declared a quarterly cash dividend of $0.09 per share of common stock. The dividend is payable on January 10, 2024, to stockholders of record as of the close of business on December 13, 2023. The Board also approved a new, three-year, $600 million share repurchase program, bringing the total amount currently available under both share repurchase programs to approximately $700 million.

07:41 EST Ree Automotive plans to scale up production by end of 2024 - The company said, "We remain disciplined and focused on reducing our operating costs as we continue to progress with our production plan. Our third quarter U.S. generally accepted accounting principlesnet loss was $24.1 million, compared to $26.2 million in Q2 2023 and $33.5 million in Q3 2022, a decrease of 28% year-over-year in GAAP net loss, and a decrease of 8% compared to the previous quarter. The year-over-year decrease was mainly driven by grants received from the UK government in Q3 2023, a decrease in share-based compensation expenses and operational efficiencies we implemented which decreased payroll and related expenses and other operational expenses. These decreases were partially offset by an increase in cost of sales attributed to material purchases for pilot vehicle builds and an increase in engineering development costs. Our Non-GAAP net loss in the quarter was $20.1 million, compared to $22.0 million in Q2 2023 and $27.3 million in Q3 2022, a decrease of 26% year-over-year and a decrease of 9% compared to the previous quarter. During the third quarter we sold approximately 2.28 million shares as part of our At-the-Market program for gross proceeds of approximately $0.7 million and we secured a bank credit facility of $15 million. We ended Q3 2023 with liquidity of $101 million comprised of $86 million cash, cash equivalents and short-term investments, and a $15 million credit facility. On November 27, 2023, we entered into a securities purchase agreements with certain investors led by our largest institutional shareholder, London-based M&G Investment Ltd. The agreement includes convertible promissory notes of $8 million in the aggregate, and warrants to purchase up to an aggregate of 1,571,710 of our Class A ordinary shares. The closing of the notes is expected to occur on or before December 11, 2023. The notes will have a term of five years, accrue interest at a rate of ten percent per annum and are convertible into our Class A Ordinary Shares, at a conversion price of $5.09 per share. We may not repay any portion of the outstanding principal amount of the notes prior to the maturity date. The conversion price of the notes is subject to customary adjustments, as well as contain certain anti-dilution protection in the event of certain issuances at a price less than the conversion price then in effect. The warrants will be immediately exercisable at an exercise price of $4.42 per ordinary share and will have a term of five years from the date of issuance. Our business plan includes scaling up the production of the low hundreds of vehicles in the US by the end of 2024, upon completion of our tooling investment plan. As a result, we plan to produce a minimum number of demo vehicles from our UK facility that will allow us to collect customer feedback, before we begin mass production in the U.S. Our ability to successfully carry out the 2024 plan is primarily dependent upon completion of the tooling investment, securing availability of materials on time and securing additional funding of approximately $20 million as currently estimated, mainly for working capital purposes."

07:36 EST MGM Resorts unveils vision for MGM Empire City - MGM Resorts unveiled its vision to transition Empire City Casino by MGM Resorts into a world-class entertainment destination, MGM Empire City, if awarded a commercial casino license for its historic Yonkers, New York site. Key elements of the phase one design include a comprehensive casino floor redevelopment and expansion, 5,000-capacity entertainment venue, state-of-the-art BetMGM sportsbook, food and beverage outlets by celebrated chefs, cocktail bars and lounges, technologically advanced meeting spaces and more.

07:34 EST Silvercorp Metals 'considering' Perseus announcements - Silvercorp Metals notes the announcements made by Perseus Mining in relation to its acquisition of a 19.9% interest in OreCorp. Silvercorp is considering these announcements to determine an appropriate course of action in the best interests of Silvercorp shareholders.

07:33 EST AbbVie to acquire ImmunoGen for $31.26 per share in cash, or EV $10.1B - AbbVie (ABBV) and ImmunoGen (IMGN) announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship cancer therapy ELAHERE, a first-in-class antibody-drug conjugate approved for platinum-resistant ovarian cancer. The acquisition accelerates AbbVie's commercial and clinical presence in the solid tumor space. Additionally, ImmunoGen's follow-on pipeline of promising next-generation ADCs further complements AbbVie's ADC platform and existing programs. Under the terms of the transaction, AbbVie will acquire all outstanding shares of ImmunoGen for $31.26 per share in cash. The transaction values ImmunoGen at a total equity value of approximately $10.1B. The boards of directors of both companies have approved the transaction. This transaction is expected to close in the middle of 2024, subject to ImmunoGen shareholder approval, regulatory approvals, and other customary closing conditions. The proposed transaction is expected to be accretive to diluted earnings per share beginning in 2027.

07:30 EST AbbVie to acquire ImmunoGen for $31.26 per share in cash

07:23 EST Rogers Sugar expects to deliver 'strong, stable financal performance' in 2024 - The company said, "Following a solid performance in 2023, we expect to continue to deliver a strong, stable financial performance in 2024. The continued strength in demand and pricing is expected to support stable organic growth for our Sugar business segment going forward. We expect our Maple segment to modestly recover during 2024 as the unfavorable inflationary pressures encountered over the last two years begin to recede. Sugar: We expect the Sugar segment to perform well in fiscal 2024. Underlying North American demand remains strong across all customer segments supported by favourable market dynamics. Improvements in pricing implemented over the last two years will continue to positively support our financial results, allowing us to mitigate the current impact of inflationary pressures on costs. However, the current labour disruption at our Vancouver refinery is expected to negatively impact our 2024 financial results, the extent of which is not yet known. The magnitude of the impact will depend mainly on the length of the strike and the potential internal incremental costs associated with servicing our Western customers impacted by the labour disruption. Since the beginning of the strike, on September 28, 2023, the Vancouver sugar refinery, which represents approximately 17% of our production of refined sugar, has been operating at approximately a third of its capacity, and we have been using some of the production of our Taber facility to support our customers in Western Canada. As at the time of preparation of this MD&A, we remain committed in reaching an agreement that is acceptable to both parties. The initial volume expectation for fiscal year 2024 was set at 800,000 metric tonnes, representing an increase of 4,700 metric tonnes as compared to fiscal year 2023. Considering the current labour situation at our Vancouver refinery, we expect our volumes will be lower in 2024 compared to 2023. The reduction in volume sold to customers will depend on the length of the labour disruption. We will continue to prioritize domestic sales and focus on meeting our commitments to our customers. We will provide updates on the expected impact of the labour disruption on sales volumes as the situation evolves. The harvest period for our sugar beet facility in Taber was completed in early November and we have received the expected quantity of beets from the growers. We are currently in the processing stage of the 2023 sugar beet campaign, with expected completion by the end of February. Based on our early assessment, we anticipate the 2023 crop to deliver between 105,000 metric tonnes and 110,000 metric tonnes of beet sugar, consistent with our expectations. The volume expectations align with the acreage contracted with the ASBG and the volume of sugar beets received. Production costs and maintenance programs for our three production facilities are expected to continue to be moderately impacted by the current inflationary market-based pressures. We continue to focus on cost control initiatives throughout our operations. Distribution costs are expected to be stable in 2024. These expenditures reflect the transfer of sugar produced between our facilities to serve our customers, including some of the costs associated with meeting the growing market demand with imported refined white sugar from Central America. Administration and selling expenses are expected to increase in 2024 as compared to 2023, due mainly to market-based increases for compensation expenditures and external services supporting our business. We anticipate our financing costs to increase in fiscal 2024 due to higher working capital needs, mainly associated with the purchase of raw sugar. We have been able to mitigate the impact of recent increases in interest rates and energy costs through our multi-year hedging strategy. We expect our hedging strategy will continue to mitigate such exposure in fiscal 2024. Spending on regular business capital projects is also expected to remain stable for fiscal 2024. We anticipate spending approximately $25 million on various initiatives. This capital spending estimate excludes expenditures relating to our recently announced production and logistic capacity expansion project in Eastern Canada, which are currently estimated to be at $70 million for fiscal 2024. Maple Products: The Maple segment financial results were lower than anticipated for 2023. This was due mainly to lower volume and lingering inflationary pressures on costs. Although we expect these financial and operating pressures to remain in the first part of fiscal 2024, we expect the Maple business segment to continue to benefit from automation initiatives at its Granby and Degelis plants. Such initiatives, combined with recently negotiated price increases, are supporting the anticipated modest recovery of our Maple business segment in 2024. The expected sales volume for 2024 is stable when compared to 2023 at approximately 43.5 million lbs. The sales volume expectation reflects the sector-wide challenging market dynamics, impacting the global demand for maple syrup. Capital investments have decreased significantly in recent years. The Maple segment is expected to spend between $1 million and $1.5 million annually on capital projects. The main driver for the selected projects is to improve productivity and profitability through automation."

07:19 EST Farmland Partners completes land conservation project in Virginia - Farmland Partners announced that they recently completed the final stage of a three-part conservation transaction along a vital migratory bird pathway in Virginia. FPI agreed in 2021 to sell DU approximately 1,268 acres of farmland adjacent to the Great Dismal Swamp National Wildlife Refuge - land that DU has prioritized for restoration and habitat protection. The unique multi-year, staged transaction provided DU maximum flexibility to secure capital for the project. The final sale consisted of more than 400 acres. "We were pleased to be able to work with our partners at Farmland Partners and look at their portfolio to see where the farmland they owned happened to be in critical conservation areas," explained DU CEO Adam Putnam. "The parcel that bubbled to the top of that priority list was the Great Dismal Swamp." "We purchased the farm in 2015 and were thrilled to have an opportunity to work with DU to protect the land for years to come," said Luca Fabbri, FPI's President and CEO. "This was a special transaction for our Company because it benefitted the environment and was profitable for our shareholders at the same time."

07:16 EST Veritone in licensing deal with Orchard Clips to boost international content - Veritone announced a content licensing agreement with Orchard Clips," a division of UK-based OR Media Group and a preeminent source of Middle Eastern content," added the company's release. "Orchard Clips will leverage Veritone's extensive network of buyers to enhance content licensing opportunities in the Americas and generate additional revenue...Orchard Clips operates as a clip-licensing business catering to both English- and Arabic-speaking broadcasters and filmmakers. As the go-to source for premium Middle Eastern content, Orchard Clips boasts a captivating collection that spans the region's history, offering a comprehensive perspective on both its past, present and future..."

07:15 EST Laser Photonics provides strategic, operational updates - Laser Photonics provided a strategic and operational update for shareholders, including business developments, achievements, and strategic direction for 2024 and beyond. In October, LPC acquired an exclusive license for its cold-cutting and high-power laser technologies from ICT Investments, an established closed-end, non-diversified private investment company focused mainly on the alternative energy sector. This license will enhance the capabilities of LPC's TiTAN series of laser-cutting technology and form the foundation of LPC's new SaberTech product line. Products: MARLIN: LPC's entry-level proprietary laser technology focused on the maritime industry, MARLIN, is now equipped with specialized laser patterns, water-tight seals and an updated form factor to cater to customer needs at a lower price point. The company plans to further expand this product line going forward to meet the evolving needs of professionals in the shipbuilding and boat manufacturing sectors; DefenseTech: LPC has adapted its CleanTech and MarkStar technology for the defense and military industry, taking advantage of the significant market potential for laser cleaning and marking technology; SaberTech: Through the incorporation of newly licensed cold-cutting and high-power laser technology acquired from ICT Investments, LPC will morph its TiTAN series of laser-cutting systems into this new product line. R&D: Development of Class I Systems: LPC is intensifying its efforts in the development of Class I systems, maintaining its competitive edge and meeting the increasing demand driven by heightened regulations and restrictions; Enhanced AI and IoT Capabilities: To maintain its market leadership and improve the customer experience, LPC has added components to its existing laser products that boost AI and IoT capabilities to remain at the forefront of technology. The company also plans to provide on-site customer support and training with AI and IoT integration, further differentiating its competitive advantage. Marketing: Strategic Partnerships: LPC is in talks to expand its distribution network and facilitate greater access to its cutting-edge technology by forging strategic partnerships with large distributors, targeting strategic partners that are in favor of onshoring component and equipment manufacturing to the United States; Commitment to Environmental Stewardship: The company is committed to delivering eco-friendly and environmentally sustainable solutions to companies worldwide, helping industries minimize their negative environmental impact; Expansion of Customer Experience Center: LPC expanded into a new location in Maitland, Florida, to serve as its customer experience center. This move will enhance the presentation and demonstration of LPC technology to customers while freeing up space at its R&D center to ramp up production capabilities.

07:12 EST Algernon receives notice of intention to grant from Chinese Patent Office - Algernon Pharmaceuticals has received a notice of intention to grant from the Chinese Patent Office for patent application No. 112654357 entitled "Compositions and Methods for Treating Non-Alcoholic Steatohepatitis" with NP-251. The invention claims treating lobular inflammation and nonalcoholic fatty liver disease, including nonalcoholic steatohepatitis and NASH-derived hepatocellular carcinoma, with Repirinast. The base claims of the patent will be valid through 2038, excluding any patent term adjustments or extensions which may provide additional protection. The Company was recently issued patents for Repirinast in NASH from the U.S. and Japan, and has also filed corresponding patent applications in Canada and Europe.

07:11 EST Ashland announces validation of science-based GHG emissions reduction targets - The Science Based Targets initiative has validated the science-based greenhouse gas, GHG, emissions reductions targets submitted by Ashland as conforming with the SBTi Criteria and Recommendations. The company has joined more than 6,500 businesses who have committed to the SBTi to reduce emissions in line with climate science. Ashland has set near-term science-based targets across scopes one, two, and three in line with 1.5 degrees C emissions scenarios to ensure the strongest ambition in the short-to -medium term committing to reduce absolute scope 1 and 2 GHG emissions 50.4 percent by FY2032 from a FY2022 baseline year and to reduce absolute scope 3 GHG emissions 50.4 percent within the same timeframe. "Ashland is proud to announce our ambitious science-based targets that reflect our purpose to responsibly solve for a better world," said Guillermo Novo, chair and chief executive officer, Ashland. "As a global leader in additives and specialty ingredients, we understand the importance of environmental, social and governance commitments. Reducing our GHG emissions helps mitigate climate change and our actions contribute to our customers sustainability goals."

07:10 EST Sophia Genetics expands work with CHU de Nimes - Sophia Genetics announced that it has expanded its work with CHU de Nimes, a regional and university hospital located in the South of France. The hospital system will use the SOPHiA DDM Platform to progress its pharmacogenomics research.

07:09 EST Trevena announces acceptance of abstract examining use of OLINVYK - Trevena announced the acceptance of an abstract based on the pRospective, case-controlled Evaluation of oLIceridine for moderate or sEVEre pain in patients with acute burn injuries, RELIEVE, study at the 2024 ABA annual meeting, being held April 9th-12th in Chicago. The study was conducted as an investigator-initiated trial and was led by David Hill, PharmD. from the Firefighters Burn Center in Memphis, TN. Dr. Hill was independently responsible for the development and submission of the abstract. The single-center, prospective, case-controlled study was dual IRB approved and included 10 patients with burn injuries admitted between April and September 2023 and treated with OLINVYK. Dosing and assessments were followed per study protocol and safety and efficacy assessed by study team daily at a minimum. Patients dosed with OLINVYK were compared to a matched historical control group which included treatment across a range of other IV opioids. "The results of the RELIEVE study will be reported during the ABA meeting and we are pleased to see additional clinical data in this patient type where new therapeutic options are needed," stated Mark A. Demitrack, M.D., Senior Vice President and Chief Medical Officer of Trevena. "We look forward to the presentation of these data in the spring."

07:08 EST Tiziana Life Sciences announces foralumab dosing of four patients in EA program - Tiziana Life Sciences announced that the company has successfully enrolled and dosed four new patients with non-active secondary progressive multiple sclerosis in the Brigham and Women's Hospital, a founding member of Mass General Brigham Healthcare System Expanded Access, EA, Program. A total of ten patients are now being followed in the EA Program. The Intermediate Size EA Program for na-SPMS represents a critical step forward in Tiziana Life Sciences' mission to provide treatment options for patients living with this debilitating disease while collecting valuable regulatory evidence about this novel investigational therapy. The EA program with foralumab, a fully human anti-CD3, has allowed Tiziana to obtain information about dosing, and drug use, including patient feedback which is critical for the design of future studies. The September 2023 release of FDA guidance entitled "Guidance on Substantial and Confirmatory Evidence of Efficacy and Safety" addresses the use of EA programs to be considered as part of confirmatory evidence. To date, two patients have been dosed for more than one year and four additional patients have been dosed for six months, all without serious side effects. These data are the first to combine imaging, immune-biomarkers, and clinical measures and safety data endpoints in patients receiving long-term intranasal foralumab. Tiziana recently initiated a Phase 2a trial in na-SPMS. Patients not eligible for the Phase 2a trial may be considered for the EA program.

07:06 EST Sol-Gel Technologies screens first patient for SGT-610 Phase 3 study - Sol-Gel Technologies announced that it has begun Phase 3 testing of SGT-610 for Gorlin syndrome with the first patient screened. Patidegib was acquired by Sol-Gel from PellePharm and is currently the only therapy in development to prevent the development of new BCC lesions in Gorlin syndrome patients. "We are pleased to initiate patient screening in this Phase 3 trial that has been long awaited by the Gorlin syndrome patient community," said Alon Seri-Levy, Ph.D., Chief Executive Officer of Sol-Gel. "To increase the probability of success of this trial we have refined screening criteria to enroll subjects with more severe disease at baseline in terms of a higher baseline number of facial BCC lesions. This may help to better demonstrate the preventive effect of the medication. Other insights that we are using in our Phase 3 trial design strategy are to pre-screen patients for a specific genetic mutation associated with Gorlin syndrome and to ease patient study compliance by reducing the number of study visits over the 12-months of treatment. We hope that our learnings to optimize this trial's design will help Sol-Gel advance this important drug candidate to Gorlin syndrome patients with no approved therapies. We anticipate SGT-610, with Orphan- and Breakthrough designation from FDA, could have a market potential of over $300 million. We look forward to discussing the experience of the Gorlin syndrome patient, the market opportunity for SGT-610, and the Phase 3 trial design during a Key Opinion Leader investor day that we are hosting on December 6th," added Dr. Seri-Levy.

07:05 EST Chico's withdraws previous FY23 outlook - Given the pending acquisition by Sycamore Partners, the company is not conducting a conference call for the third quarter. In addition, the company is not providing a financial outlook and is withdrawing its previously issued outlook for fiscal 2023.

07:03 EST Orchard Therapeutics receives U.S. fast track designation for OTL-203 - Orchard Therapeutics announced the U.S. Food and Drug Administration, FDA, has granted Fast Track designation to OTL-203, an investigational hematopoietic stem cell gene therapy being developed for the potential treatment of the Hurler subtype of mucopolysaccharidosis type I. "At Orchard Therapeutics, we are applying our HSC gene therapy platform to indications where we believe it is clinically differentiated and has the greatest potential to make a paradigm-shifting impact on the treatment landscape," said Leslie Meltzer, Ph.D., chief medical officer. "We are encouraged that OTL-203 has been granted Fast Track designation because new treatment options are urgently needed for children with MPS-IH, as the current standard of care is associated with significant morbidity and mortality. Moreover, existing treatment options do not adequately address the broad range of clinical manifestations of the disease, including those that are most burdensome and have a high impact on quality of life. We look forward to initiating our global registrational trial in December to evaluate the efficacy and safety of OTL-203 compared to allogeneic HSCT."

07:02 EST Nuvini, Semantix partner to implement AI in Nuvini-owned companies - Nuvini Group (NVNI) and Semantix, Inc. (STIX) announces a strategic partnership. With a shared vision of leveraging the potential of Artificial Intelligence, both companies are set to embark on an exciting journey to enhance and optimize the operations of Nuvini's portfolio of companies. Under the leadership of Leonardo dos Santos, Semantix has assembled a highly experienced team of AI Experts. The partnership aims to apply the power of AI harnessed by Semantix to optimize and drive innovation in these companies. As the collaboration unfolds, Semantix's AI Experts will work closely with Nuvini's leadership to identify AI applications that align with each company's unique needs and objectives. The partnership is set to commence in November 2023, and both parties are committed to ensuring a smooth and effective integration of AI solutions across Nuvini's business entities. The goal is to achieve greater operational efficiency, data-driven decision-making, and a competitive edge in Nuvini's respective industries, by providing AI Applications and AI Solutions powered by Semantix.

06:58 EST Geo Group CEO Jose Gordo to depart, Brian Evans to succeed - The GEO Group announced that following discussions between GEO and its CEO, Jose Gordo, the parties have agreed that Gordo will be departing as Chief Executive Officer and as a Board member on mutually agreeable terms and transitioning to the role of an advisor, effective December 31, 2023. Under the agreed terms of his departure, Gordo will enter into a fixed, 18-month advisory services agreement upon payment terms agreed to by the parties, pursuant to which Gordo will advise the Company with respect to litigation, client relations, operational issues, growth opportunities, financial management, and debt restructuring. The company is seeking to continue Gordo's services in these specific areas to benefit from his many years of experience in the industry, the deep relationships he has forged inside the company and with its industry partners, his global operating perspectives, and his specific expertise in a specialized industry. Brian Evans, who has been with the company for 23 years and has served as the company's CFO for 14 years, has been appointed CEO, effective January 1, 2024. Shayn March, Executive Vice President, Finance and Treasurer, has been appointed Acting CFO, effective January 1, 2024. The company and its Board of Directors will work with an external search firm to identify a permanent CFO. Also effective January 1, 2024, Wayne Calabrese has been appointed President and COO. Calabrese joined the company in 1989, retiring as its President and COO at the end of 2010. Following his service as a company advisor, Calabrese rejoined the Company on a full-time basis in 2021 as head of the Legal Department. In 2022, Calabrese was appointed to his current position as Senior Vice President and COO. In addition, the company confirmed that Dr. George Zoley, the company's Founder and Executive Chairman, will step down as Executive Chairman on June 30, 2026, at the end of his current employment term under his Executive Chairman Employment Agreement. Beginning on July 1, 2026, Dr. Zoley will continue his unparalleled 40-plus year industry leadership role as an Advisor to the company while continuing to serve as the company's non-Executive Chairman of the Board of Directors, subject to shareholder approval.

06:51 EST The Buckle reports November SSS down 10.8% - The Buckle announced that comparable store net sales, for stores open at least one year, for the 4-week period ended November 25, 2023 decreased 10.8% from comparable store net sales for the 4-week period ended November 26, 2022. Net sales for the 4-week fiscal month ended November 25, 2023 decreased 10.1% to $106M from net sales of $117.9M for the prior year 4-week fiscal month ended November 26, 2022.

06:43 EST Uranium Energy, TerraPower enter MOU to establish uranium supply chains - TerraPower and Uranium Energy announced a memorandum of understanding, or MOU, with objectives of reestablishing domestic supply chains of uranium fuel. This MOU will allow TerraPower and UEC to explore the potential supply of uranium for TerraPower's first-of-kind Natrium reactor and energy storage system. The Natrium demonstration project, being built in Kemmerer, Wyoming, will be a commercial scale plant upon completion and will begin operations within a decade. UEC and TerraPower have made significant investments in the nuclear fuel cycle and commercial scale deployment of clean energy projects that will directly benefit the U.S. economy. This includes delivering carbon-free power, high paying jobs, and providing support for establishing a robust U.S. nuclear fuel supply chain for Small Modular and Advanced Reactors and their high assay low enriched uranium requirements. These new reactors, like TerraPower is advancing in Wyoming, present innovative leaps in technology that can help address the world's growing clean energy needs with abundant 24/7, carbon-free power. SMRs and ARs present the fastest growing segment of nuclear energy in the United States and need a secure, domestic fuel supply chain. The first step of the supply chain is uranium, and UEC's Wyoming resources have the critical mass to be a highly reliable source of uranium for American HALEU and a good strategic fit to supply TerraPower's Natrium reactor.

06:34 EST TD Bank names Alan MacGibbon as Chair of the Board of Directors - TD Bank Group is pleased to announce the appointment of Alan MacGibbon as Chair of the Board of Directors, effective February 1, 2024. Alan will succeed Brian Levitt, who will also retire from the Board following the Bank's annual meeting of shareholders on April 18, 2024. Levitt joined the TD Board in 2008 and has served as Chair since 2011.

06:34 EST TD Bank expects 'challenging' environment in FY24 - For fiscal 2024, it will be challenging for the Bank to meet its medium-term adjusted EPS growth target range of 7-10% and return on equity target of 16+% as it navigates a complex macroeconomic environment, expected further normalization in PCLs and critical business investments. "We enter 2024 from a position of strength, with proven resiliency, a powerful brand, and a strong capital position," said CEO Masrani. "I want to thank our more than 95,000 colleagues across the globe who bring TD's purpose to life every day."

06:22 EST Walgreens launches Rx Savings Finder - Walgreens announced the launch of its new Rx Savings Finder, a simple-to-use digital tool designed to help customers save money on prescription medications. Rx Savings Finder finds free, third-party discount cards, providing patients with a quick and easy way to find lower prices on their Walgreens medications. The Walgreens Rx Savings Finder tool helps to alleviate cost concerns for patients by offering savings on thousands of medications as well as providing transparent pricing before they reach the checkout counter. Available online at Walgreens.RxSense.com, the tool is available to all Walgreens customers for free, with no monthly subscription or yearly membership needed.

06:09 EST ProKidney appoints Nikhil Pereira-Kamath as Chief Business Officer - ProKidney appointed Nikhil Pereira-Kamath, VP of Business Development & Innovative Solutions, to Chief Business Officer. Pereira-Kamath joined ProKidney earlier this year as VP of Business Development & Innovative Solutions. Prior to joining ProKidney, he was CEO and subsequently Executive Chairman, a role he continues to hold, of Africa Healthcare Network, the largest independent provider of dialysis and kidney care in sub-Saharan Africa. Pereira-Kamath co-founded AHN in 2015. Pereira-Kamath started his career as an analyst at Morgan Stanley in its Healthcare Investment Banking division covering large pharma, biotech and pharma services. Following that, he worked at Berkshire Partners.

06:04 EST KKR, Hologic and Ajax Health create new cancer detection platform - KKR (KKR) announced a new platform established with investments from KKR and Hologic (HOLX). The new platform, named Maverix Medical, will be managed by Ajax Health under the leadership of Duke Rohlen. Maverix will develop and acquire innovative technologies and commercial operations within the lung cancer disease category. KKR and Ajax Health will contribute existing portfolio company Serpex Medical to the platform. Serpex Medical develops steerable technology that can target lung tissue for biopsy or delivery of therapy. KKR is investing in Maverix through its Health Care Strategic Growth strategy. Additional terms of the transaction were not disclosed.

05:36 EST Richemont says has 'no financial obligations' towards Farfetch - Following the recent media reports on and announcement made by Farfetch (FTCH) on November 28, Richemont (CFRSF) said in a statement that it has "no financial obligations towards FARFETCH and notes that it does not envisage lending or investing into FARFETCH. Richemont is carefully monitoring the situation, including reviewing its options in respect of its arrangements with FARFETCH announced on August 24, 2022, which remain subject to certain terms and outstanding conditions. Neither Richemont Maisons nor YOOX NET-A-PORTER have currently adopted FARFETCH Platform Solutions and they continue to operate on their own platforms." Richemont said it will make a further announcement "if and when appropriate." Reference Link

05:21 EST Vail Resorts to acquire Crans-Montana Mountain Resort in Switzerland - Vail Resorts announced that it has entered into an agreement to acquire Crans-Montana Mountain Resort in Switzerland from CPI Property Group, or CPIPG. Crans-Montana Mountain Resort spans over 1,400 meters of skiable vertical terrain, and 140 kilometers of trails. Accessible from five airports and by train, Crans-Montana Mountain Resort is located in the Valais canton of Switzerland, approximately two and a half hours from Geneva and less than four hours from Milan and Zurich. The resort is two and a half hours away from the company's other owned and operated European resort in Andermatt-Sedrun.Crans-Montana Mountain Resort is a top ski destination in the heart of the Swiss Alps, offering breathtaking views of the Matterhorn and the Mont Blanc, and has been recognized as one of the best ski resorts in Europe. Crans-Montana has a legacy of being a renowned outdoor sports destination, with signature events such as the Ski World Cup, Mountain Bike World Cup, Omega European Masters, and other championships, the Caprices Festival and more. The commune of Crans-Montana has gourmet restaurants and luxury retail stores, as well as stylish five-star hotels, including the recently developed Six Senses lodge and spa, a luxury 45-room ski-in, ski-out chalet-style property situated above the main gondola.

05:14 EST HP Enterprise announces expanded collaboration with Nvidia - HP Enterprise (HPE) announced an expanded strategic collaboration with Nvidia to build an enterprise computing solution for generative AI. The co-engineered, pre-configured AI tuning and inferencing solution enables enterprises of any size to quickly customize foundation models using private data and deploy production applications anywhere, from edge to cloud. The offering removes the complexity of developing and deploying GenAI infrastructure with a full-stack AI tuning and inferencing solution from HPE and Nvidia.